chr10-68988861-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015634.4(KIFBP):c.29G>T(p.Cys10Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,614,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015634.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIFBP | NM_015634.4 | c.29G>T | p.Cys10Phe | missense_variant | 1/7 | ENST00000361983.7 | NP_056449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIFBP | ENST00000361983.7 | c.29G>T | p.Cys10Phe | missense_variant | 1/7 | 1 | NM_015634.4 | ENSP00000354848 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152270Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251162Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135880
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461886Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 727242
GnomAD4 genome AF: 0.000125 AC: 19AN: 152388Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.29G>T (p.C10F) alteration is located in exon 1 (coding exon 1) of the KIF1BP gene. This alteration results from a G to T substitution at nucleotide position 29, causing the cysteine (C) at amino acid position 10 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 10, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at